Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio, a specialist in applying AI to drug discovery that was set up last year, but until now has ...

BioSpace is proud to present its NextGen: Class of 2026, a list of the hottest new life sciences companies in the United States. To come up with this list, BioSpace identified companies that announced ...

AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI biotech startup Coefficient Bio in a $400 million stock deal, according to ...

Newly uncloaked Stipple Bio is connecting the dots toward multiple early-stage clinical studies for its lead precision oncology asset, buoyed by a $100 million series A financing round. The “heavily ...

Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, AbbVie and others already use Claude in their operations. AI leader Anthropic ...

Anthropic is making strides in the AI space. The AI firm has acquired stealth startup Coefficient Bio for over $400 million in an all-stock deal. Closed in early April 2026, the acquisition pulls a ...

Anthropic has acquired biotech startup Coefficient Bio in a deal valued at around $400 million, reported The Information on Friday. As part of the acquisition, the New York–based startup’s team will ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded barely eight months ago, in an all-stock deal worth just over $400 million. The acquisition brings a team of fewer than 10 ...

Anthropic has acquired Coefficient Bio in a stock deal worth about $400 million. The New York-based Biotech AI Startup had largely operated in stealth mode and was known for building biology-focused ...